Logo  


Partner area


 
  HOME About us Technologies Services Consulting Business Development
 

 

 

 

 

 

 

 

Start



Events

10th Annual
Peptides & Oligonucleotides Congress
30-31 March, 2023
London, UK

Invited lecture:
Lipid Nanoparticles: A Game Changing Strategy for Oral Peptide Drug Delivery
Prof. Dr. A. Bernkop-Schnürch
more...



 

 

Vials

 

 

Laboratory

 

 

 

 

 

 

 

The Drug Delivery Network


ThioMatrix is specialised on the development of non-invasive drug delivery systems utilizing its core technologies: the Thiomer Technology and SEDDS Technology. Due to the great potential of these technologies the efficacy of non-invasively delivered:

  • therapeutic peptides

  • peptidomimetics

  • nucleic acids such as oligonucleotides, plasmid DNA and siRNA

  • class III drugs according to the biopharmaceutical classification system (BCS)

  • drugs being substrate of efflux pumps such as anticancer drugs

can be tremendously improved. A wide network of partnerships and collaborations with hospitals, veterinary institutions, CROs and universities has been established to conduct preclinical through to clinical development of our delivery products. This network coupled to our technologies and expertise gives us the edge to reduce the time to market to develop the optimal delivery systems for your therapeutic candidates. To learn more about our drug delivery technologies, please visit the technology section where you will also find the results of various in vivo studies demonstrating the advantages of our novel drug delivery products.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  News

A. Bernkop-Schnürch, CSO ThioMatrix, was honored with the PHOENIX Award 2022
more....

 

Contact

 

Careers
Downloads
Site map

a



ThioMatrix Hotline:
+43 512 890046
Mo-Th 9.00-17.00
and Fr 9.00-14.00


Drucker Print this page

 

 

 

 

 

     

© All rights reserved | Site map | Disclaimer | Imprint | Contact |

 

GR

TM